No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
510 |
4. Check minimum number of eventsNone |
510 |
5. Include endpointsNone |
510 |
6. Filter based on genotype QC (FinnGen only) |
510 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified paralytic syndromes
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5694 | 2528 | 3080 |
| Only index persons | 4141 | 1913 | 2228 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.07 | 0.09 |
| Only index persons | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 46.76 | 48.42 | 45.00 |
| Only index persons | 38.07 | 42.26 | 34.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 510 | 274 | 236 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 47.69 | 43.62 | 52.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 455
- Matched controls
- 4551
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
3160.7
205.4
183
*
G83.8
ICD-10 Finland
Other specified paralytic syndromes
+∞
124.9
114
*
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
+∞
84.0
78
*
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
+∞
65.2
61
*
AA1AD
NOMESCO Finland
CT of head and brain
3.8
32.8
175
638
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.9
32.5
72
94
G81.9
ICD-10 Finland
Hemiplegia, unspecified
346.8
32.3
32
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.3
32.2
92
175
3449X
ICD-9 Finland
Other paralytic syndromes, Paralysis, unspecified
+∞
30.6
29
*
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
263.8
24.9
25
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.9
23.8
112
354
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.9
21.4
55
89
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.7
21.2
77
189
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.9
20.5
44
54
N03AX14
ATC
levetiracetam; systemic
11.1
19.5
37
36
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.8
19.0
35
32
R51.80
ICD-10 Finland
Headache
3.3
19.0
107
384
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.4
18.6
71
183
N03AX12
ATC
gabapentin; oral
3.2
18.5
110
410
L28
ICPC
Limited function/disability (L)
3.3
18.3
104
374
N03AF02
ATC
oxcarbazepine; oral
9.5
18.0
37
42
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.5
17.8
66
165
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
17.5
94
323
A28
ICPC
Limited function/disability NOS
3.2
17.2
100
365
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
17.0
102
380
N03AG01
ATC
valproic acid; systemic, rectal
4.5
16.8
62
154
TKC20
NOMESCO Finland
Catheterisation of bladder
5.4
16.6
51
104
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.4
16.5
86
289
N03AX09
ATC
lamotrigine; oral
5.8
16.1
46
86
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.5
15.9
59
147
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
15.8
61
158
TAB00
NOMESCO Finland
Lumbar puncture
6.2
15.5
42
73
N03AF01
ATC
carbamazepine; oral, rectal
5.1
15.3
49
105
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
21.9
14.8
21
10
R4120
NOMESCO Finland
Occupational therapy
4.6
14.8
53
128
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
13.2
14.6
25
20
R4110
NOMESCO Finland
Physiotherapy
2.4
14.5
150
766
N05CD07
ATC
temazepam; oral
3.2
13.8
80
287
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
13.7
63
191
R42
ICD-10 Finland
Dizziness and giddiness
2.6
13.6
118
546
N02AA05
ATC
oxycodone; systemic
3.0
13.4
85
326
N05AA02
ATC
levomepromazine; systemic
5.3
13.3
41
84
R53
ICD-10 Finland
Malaise and fatigue
2.5
13.3
119
562
N05BA01
ATC
diazepam; systemic, rectal
3.0
13.1
82
311
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.7
13.1
45
104
XA800
NOMESCO Finland
Neuropsychological investigation
5.5
12.9
38
74
N05AX08
ATC
risperidone; systemic
3.6
12.7
59
180
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
12.5
181
1073
R06.0
ICD-10 Finland
Dyspnoea
2.4
12.4
124
614
N03AX16
ATC
pregabalin; oral
2.3
12.4
132
678
N05AH04
ATC
quetiapine; oral
2.6
12.3
101
452
N06AX16
ATC
venlafaxine; oral
2.9
12.2
78
300
R20.2
ICD-10 Finland
Paraesthesia of skin
4.1
12.2
48
127
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
12.1
116
561
N18
ICPC
Paralysis/weakness
10.5
12.1
23
23
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.7
12.1
41
94
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
11.8
150
833
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.8
11.8
51
147
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
11.7
200
1259
N03AE01
ATC
clonazepam; systemic
4.3
11.7
43
107
G35
ICD-10 Finland
Multiple sclerosis
10.4
11.6
22
22
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
11.6
55
171
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
11.5
11
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
+∞
11.5
11
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
11.5
92
406
N99
ICPC
Neurological disease other
17.6
11.3
17
10
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
11.2
97
443
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.6
11.1
32
61
UKC02
NOMESCO Finland
Cystoscopy
2.6
11.0
89
393
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.1
11.0
24
31
N06AB04
ATC
citalopram; systemic
2.3
10.9
121
627
N06AX11
ATC
mirtazapine; oral
2.1
10.8
162
959
R11
ICD-10 Finland
Nausea and vomiting
3.2
10.8
57
193
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
22.1
10.7
15
7
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
10.7
87
384
SPAT1229
SPAT
Assessment of need for aid
3.4
10.7
53
171
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
61.5
10.7
12
*
R52.2
ICD-10 Finland
Other chronic pain
5.5
10.7
31
60
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
10.5
56
190
F44.4
ICD-10 Finland
Dissociative motor disorders
+∞
10.5
10
*
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
+∞
10.5
10
*
M03BX01
ATC
baclofen; systemic
9.9
10.4
20
21
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
10.3
70
279
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
10.3
84
372
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
10.3
67
261
L17
ICPC
Foot/toe symptom/complaint
2.2
10.1
125
677
R33
ICD-10 Finland
Retention of urine
3.6
10.1
46
139
N05AF03
ATC
chlorprothixene; systemic
5.7
10.0
28
52
N88
ICPC
Epilepsy
20.6
9.9
14
7
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
9.7
75
321
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.7
9.7
27
50
A06AD11
ATC
lactulose; oral
2.5
9.6
78
343
WX892
NOMESCO Finland
Monitored bed care
3.5
9.6
45
139
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.7
9.5
41
119
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
9.4
9
*
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
+∞
9.4
9
*
M79.6
ICD-10 Finland
Pain in limb
1.9
9.4
171
1079
N02BE01
ATC
paracetamol; systemic, rectal
2.2
9.3
384
3243
NA1AD
NOMESCO Finland
Cervical spine CT examination
5.2
9.3
28
57
183
Kela drug reimbursment
Lamotrigin and topiramate
14.0
9.2
15
11
N02AX02
ATC
tramadol; systemic, rectal
1.9
9.1
195
1299
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.1
107
566
G83.4
ICD-10 Finland
Cauda equina syndrome
37.5
9.1
11
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
9.1
138
813
A02BC02
ATC
pantoprazole; systemic
1.8
9.0
285
2166
R60.0
ICD-10 Finland
Localized oedema
2.8
8.9
59
231
A29
ICPC
General symptom/complaint other
2.7
8.9
62
250
WX110
NOMESCO Finland
Local anesthesy
1.9
8.9
309
2419
C03CA01
ATC
furosemide; systemic
2.0
8.9
130
753
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
8.8
113
620
G44.2
ICD-10 Finland
Tension-type headache
2.5
8.7
70
307
N05AH03
ATC
olanzapine; systemic
3.3
8.7
43
139
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
8.7
86
417
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
8.6
38
112
N28
ICPC
Limited function/disability (N)
9.2
8.6
17
19
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.8
8.6
35
97
M54.1
ICD-10 Finland
Radiculopathy
4.7
8.5
28
63
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.3
8.4
30
73
K90
ICPC
Stroke/cerebrovascular accident
6.0
8.4
22
38
SPAT1216
SPAT
Assessment of functional ability
2.4
8.4
76
356
34099
ICD-8 Finland
Multiple sclerosis
+∞
8.4
8
*
N05BA04
ATC
oxazepam; oral
2.0
8.3
116
654
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
8.3
67
292
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
6.7
8.3
20
31
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
8.2
127
745
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
8.2
85
421
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
8.4
8.2
17
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
8.1
72
332
S06.0
ICD-10 Finland
Concussion
2.6
8.1
61
258
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.7
8.1
22
40
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
8.0
7.9
17
22
G43.9
ICD-10 Finland
Migraine, unspecified
3.6
7.9
35
104
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.9
175
1166
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.6
7.8
19
30
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
5.7
7.8
21
38
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
45.8
7.7
9
*
F60.7
ICD-10 Finland
Dependent personality disorder
25.5
7.6
10
*
N03AX18
ATC
lacosamide; systemic
25.5
7.6
10
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.3
7.6
37
119
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.3
7.5
36
114
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
7.5
100
554
C07AB07
ATC
bisoprolol; oral
1.7
7.4
195
1365
109
Kela drug reimbursment
Multiple sclerosis
9.6
7.3
14
15
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
9.6
7.3
14
15
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.4
7.3
18
29
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
7.3
7
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
7.2
83
429
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.5
7.2
16
22
N06AB03
ATC
fluoxetine; oral
2.4
7.2
61
274
G40.89
ICD-10 Finland
Other epilepsy
30.5
7.2
9
*
A04
ICPC
Weakness/tiredness general
2.4
7.2
65
301
H53.2
ICD-10 Finland
Diplopia
4.5
7.1
24
56
P29
ICPC
Psychological sympt/compl other
3.5
7.1
32
97
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.0
7.1
40
141
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.0
7.1
27
71
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.7
7.1
46
180
SPAT1254
SPAT
Administration of medicine
2.2
7.0
74
372
R52.9
ICD-10 Finland
Pain, unspecified
2.7
6.9
47
185
R55
ICD-10 Finland
Syncope and collapse
2.5
6.9
54
234
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.1
6.9
25
63
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
6.8
54
236
N06AA09
ATC
amitriptyline; systemic
2.6
6.8
50
209
3459X
ICD-9 Finland
Epilepsy, unspecified
40.7
6.8
8
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
6.7
53
232
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
6.7
81
429
U05
ICPC
Urination problems other
3.4
6.7
31
97
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.9
6.6
25
66
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.6
6.6
21
47
XKD00
NOMESCO Finland
Uroflowmetry
2.2
6.5
70
353
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
70.8
6.4
7
*
XCK00
NOMESCO Finland
Perimetry
3.1
6.4
34
117
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
14.6
6.4
10
7
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
6.4
51
223
U07
ICPC
Urine symptom/complaint other
3.2
6.4
32
106
C09AA05
ATC
ramipril; oral
1.9
6.4
107
643
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.5
6.4
28
84
A02BC03
ATC
lansoprazole; oral
1.8
6.3
129
825
G40
ICD-10 Finland
Epilepsy
9.4
6.3
12
13
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
6.3
6
*
34308
ICD-8 Finland
Cerebral spastic infantile paralysis, Alia definita
+∞
6.3
6
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
6.3
6
*
3001A
ICD-9 Finland
Neurotic disorders, Hysteria[KONVERSIOHÄIRIÖ]
+∞
6.3
6
*
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
6.3
6
*
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
+∞
6.3
6
*
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
+∞
6.3
6
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.2
82
449
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
27.1
6.2
8
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
27.1
6.2
8
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
27.1
6.2
8
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.6
6.2
20
45
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
6.2
47
200
S18
ICPC
Laceration/cut
1.7
6.2
175
1233
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
6.2
33
114
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.4
6.2
21
50
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.2
132
857
M89.0
ICD-10 Finland
Algoneurodystrophy
12.7
6.1
10
8
G41.9
ICD-10 Finland
Status epilepticus, unspecified
12.7
6.1
10
8
T90.5
ICD-10 Finland
Sequelae of intracranial injury
8.8
6.1
12
14
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
6.1
121
767
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
10.2
6.1
11
11
N86
ICPC
Multiple sclerosis
10.2
6.1
11
11
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.7
6.0
16
29
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
6.0
118
745
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
6.0
35
128
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
264
1159
3.65
45.77
3.9
2.0
u/l
243.5
224.8
0.10
254
1098
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
109
351
3.68
28.82
3.6
2.4
u/l
28.5
46.7
0.76
92
288
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
299
1727
2.77
27.67
9.1
5.9
mmol/l
1.2
1.2
0.94
282
1579
(3044290) Cell count panel - Cerebral spinal fluid
43
70
6.62
25.78
1.3
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
312
1918
2.61
24.25
9.0
6.5
mmol/l
1.2
1.2
0.68
282
1619
(3016018) Differential panel - Cerebral spinal fluid
25
24
10.90
22.84
1.2
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
140
597
2.85
22.67
4.9
2.9
e6/l
2.0
2.3
0.24
76
309
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
115
440
3.08
22.65
3.5
2.9
umol/l
7.9
7.9
0.00
99
383
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
46
91
5.46
22.57
1.3
1.2
mg/l
464.4
415.8
0.57
40
86
(3023410) Appearance of Cerebral spinal fluid
29
36
8.48
21.97
1.2
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
42
79
5.70
21.74
1.2
1.2
mmol/l
3.7
3.8
0.19
35
72
(3002582) Erythrocytes [#/volume] in Urine
218
1182
2.47
21.45
5.9
3.1
e6/l
48.5
104.8
0.46
172
901
(3018418) pH of Serum or Plasma
215
1159
2.48
21.42
4.9
3.7
ph
7.4
7.4
0.15
34
213
(3024561) Albumin [Mass/volume] in Serum or Plasma
274
1655
2.42
21.08
5.7
4.5
g/l
35.6
35.9
0.39
259
1556
(3013826) Glucose [Moles/volume] in Serum or Plasma
345
2316
2.51
20.85
8.6
4.5
mmol/l
6.6
6.7
0.85
335
2164
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
26
9.64
20.12
1.1
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
139
626
2.68
19.98
4.5
2.7
e6/l
0.6
1.1
1.78
74
338
(36304419) Bacteria [Presence] in Urine
194
1025
2.44
19.90
5.6
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
237
1368
2.37
19.89
6.8
3.7
e6/l
85.1
99.2
0.13
178
960
(3023368) Bacteria identified in Blood by Culture
192
1012
2.44
19.77
5.5
4.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
152
726
2.56
19.29
5.0
3.3
ng/l
457.6
318.0
0.17
112
554
(3031040) Bacteria [#/volume] in Urine by Automated count
364
2562
2.47
18.90
7.8
4.2
e6/l
4824.4
1802.9
—
7
48
(3012095) Magnesium [Moles/volume] in Serum or Plasma
132
601
2.61
18.40
4.2
3.2
mmol/l
0.8
0.8
0.66
126
566
(3026008) Bacteria identified in Urine by Culture
202
1117
2.34
18.39
5.6
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
235
1390
2.28
18.19
6.0
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
226
1327
2.26
17.68
8.5
5.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
415
2.82
17.67
2.3
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
83
5.01
17.58
1.3
1.3
e6/l
347.3
223.1
0.24
25
70
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
83
5.01
17.58
1.3
1.2
e6/l
4.9
5.7
0.07
23
67
(3030467) Casts [#/volume] in Urine by Automated count
192
1059
2.30
17.39
5.9
3.0
e6/l
0.3
0.4
0.22
149
782
(3014111) Lactate [Moles/volume] in Serum or Plasma
89
340
2.96
17.29
9.2
7.4
mmol/l
1.7
1.4
0.90
83
326
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
307
2065
2.22
16.88
8.2
5.9
umol/l
9.8
11.3
2.11
298
1953
(3022217) INR in Platelet poor plasma by Coagulation assay
109
470
2.68
16.83
17.3
22.6
inr
1.4
1.3
0.32
13
58
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
101
419
2.76
16.81
2.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
130
613
2.50
16.68
2.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
227
1369
2.19
16.28
5.0
3.1
u/l
31.7
31.5
0.02
215
1307
(3003396) Base excess in Arterial blood by calculation
100
420
2.72
16.22
7.4
7.6
mmol/l
0.6
1.1
0.46
83
340
(3015377) Calcium [Moles/volume] in Serum or Plasma
218
1304
2.17
15.86
3.8
3.3
mmol/l
2.3
2.4
0.13
196
1161
(3000850) Epithelial cells [#/volume] in Urine
154
802
2.32
15.71
4.2
2.6
e6/l
6.4
5.9
0.12
146
704
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
26
42
6.47
15.61
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
43
6.32
15.27
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
40
6.52
15.15
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
80
310
2.87
15.06
11.8
9.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
243
1548
2.09
14.69
11.3
8.7
inr
1.2
1.2
0.35
68
450
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
16
10.29
14.09
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
15
10.27
13.18
1.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
33
78
4.45
13.11
3.8
2.8
umol/l
31.4
38.5
0.62
28
65
(3005719) IgG [Mass/volume] in Serum or Plasma
76
308
2.72
13.08
2.9
2.8
g/l
10.4
10.5
0.08
70
279
(3001604) Monocytes [#/volume] in Blood
291
2035
2.00
13.03
9.5
5.5
e9/l
0.6
0.6
0.17
251
1769
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
120
3.72
12.95
3.0
2.5
g/l
9.9
10.2
0.10
37
101
(3006315) Basophils [#/volume] in Blood
291
2043
1.99
12.80
9.5
5.5
e9/l
0.0
0.0
0.08
250
1778
(3013115) Eosinophils [#/volume] in Blood
298
2115
1.98
12.64
9.9
5.9
e9/l
0.2
0.2
0.21
258
1866
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
157
890
2.10
12.57
2.7
1.8
mg/l
0.9
1.2
0.75
130
676
(3026782) Osmolality of Urine
141
767
2.16
12.57
4.7
2.8
mosm/kgh2o
537.5
559.6
0.59
130
651
(3021447) Carbon dioxide [Partial pressure] in Venous blood
81
347
2.59
12.46
8.1
3.9
kpa
6.0
5.8
0.91
76
336
(3003458) Phosphate [Moles/volume] in Serum or Plasma
105
508
2.34
12.41
5.3
5.4
mmol/l
1.0
1.0
0.12
98
467
(3020779) Urea [Moles/volume] in Serum or Plasma
77
323
2.63
12.36
5.2
6.2
mmol/l
8.8
9.1
0.13
70
305
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
22
7.96
12.35
1.0
1.0
u/l
1.2
1.1
—
7
11
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
134
3.50
12.34
3.0
2.4
g/l
7.0
7.5
1.04
36
99
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
134
3.50
12.34
3.0
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
134
3.50
12.34
3.0
2.4
g/l
3.9
3.7
0.21
35
94
(3002032) Base excess in Venous blood by calculation
80
343
2.58
12.28
8.2
3.9
mmol/l
1.9
1.8
0.04
67
269
(3019198) Lymphocytes [#/volume] in Blood
293
2087
1.95
12.08
9.6
5.6
e9/l
2.1
2.0
0.17
261
1852
(3013650) Neutrophils [#/volume] in Blood by Automated count
321
2364
1.97
11.92
14.5
8.9
e9/l
4.0
4.1
0.46
283
2076
(40758558) Short blood count panel - Blood
169
1001
2.03
11.91
12.3
6.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
232
2.85
11.81
2.9
2.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
128
3.49
11.77
3.1
2.5
g/l
2.9
3.2
1.48
35
96
(3052851) Hemolysis interference index of Serum or Plasma
38
109
3.69
11.65
5.0
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
77
4.22
11.56
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
77
4.22
11.56
1.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
196
1234
1.96
11.53
3.2
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
231
1537
1.92
11.51
2.3
1.9
pmol/l
85.1
95.4
2.99
142
831
(3037467) Urinalysis macro (dipstick) panel - Urine
357
2747
2.00
11.41
6.8
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
161
951
2.01
11.35
2.4
2.1
mg/l
3.0
3.1
0.44
132
813
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
389
3089
2.09
11.34
11.8
7.2
u/l
85.7
77.7
1.56
376
2905
(3011397) Hemoglobin [Presence] in Urine by Test strip
148
852
2.04
11.18
4.5
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
94
457
2.30
10.90
2.3
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
240
1638
1.88
10.88
2.7
2.3
nmol/l
71.8
75.9
1.23
217
1484
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
55
207
2.86
10.84
2.1
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
287
2.58
10.74
2.0
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
262
1851
1.85
10.54
9.5
5.7
%
0.7
0.7
0.05
255
1736
(3019069) Monocytes/100 leukocytes in Blood
268
1916
1.84
10.29
10.8
5.9
%
8.9
8.6
0.69
261
1811
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
71
4.11
10.17
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
266
1906
1.83
10.06
10.0
5.6
%
2.9
2.9
0.07
259
1784
(3002030) Lymphocytes/100 leukocytes in Blood
272
1963
1.83
10.04
10.0
5.7
%
28.1
28.0
0.03
262
1842
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
192
1251
1.86
9.83
4.1
2.4
u/l
51.1
55.4
1.18
185
1163
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
16
8.31
9.77
3.3
2.3
umol/l
164.0
76.7
—
8
9
(3035350) Ketones [Presence] in Urine by Test strip
270
1956
1.81
9.73
4.9
3.5
estimate
0.0
0.0
0.00
39
376
(3019060) Gas panel - Arterial blood
59
244
2.60
9.69
6.1
3.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
83
3.78
9.68
13.4
3.1
—
—
—
0
0
(4027681)
17
29
6.03
9.65
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
221
1521
1.80
9.35
5.9
3.5
ng/l
291.9
39.1
0.46
156
984
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
105
3.40
9.34
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
100
3.46
9.33
10.7
2.7
u/ml
0.3
0.3
1.04
16
51
(4198724)
14
20
7.17
9.33
3.6
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
147
894
1.91
9.24
1.7
1.6
nmol/l
19.3
20.6
0.52
128
759
(3018010) Neutrophils/100 leukocytes in Blood
266
1939
1.78
9.21
10.1
5.5
%
56.7
57.2
0.28
258
1827
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
7
19.01
8.97
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
25
6.15
8.70
1.3
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
934
1.86
8.69
3.1
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
110
619
1.99
8.63
2.3
2.3
umol/l
13.5
13.5
0.00
103
571
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
167
1088
1.80
8.28
3.7
3.1
ng/l
1005.5
1374.5
1.12
146
910
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
257
2.42
8.24
3.7
3.9
mmol/l
1.6
1.9
0.18
44
193
(3021601) Nitrite [Presence] in Urine by Test strip
264
1965
1.71
8.12
6.7
4.7
estimate
0.0
0.0
0.50
42
366
(3017143) Hepatitis C virus Ab [Presence] in Serum
89
475
2.06
8.05
1.6
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
266
1988
1.71
8.02
5.1
3.5
estimate
0.0
0.0
0.50
40
353
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
216
2.51
7.98
1.7
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
31
5.30
7.97
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
242
2.43
7.93
2.8
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
65
312
2.24
7.69
2.4
2.3
ug/l
7.0
7.2
0.03
54
282
(4306422)
24
67
3.71
7.66
1.2
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
18
6.80
7.63
2.3
5.3
%
107.1
94.4
0.57
12
18
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
1841
1.68
7.50
4.3
3.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
192
2.53
7.42
8.3
10.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
65
3.66
7.22
1.3
1.3
u/ml
2.2
5.3
—
5
23
(3019150) Specific gravity of Urine by Refractometry
137
876
1.77
7.08
5.7
3.8
kg/l
1.0
1.0
0.55
29
113
(3042936) Bacteria identified in Isolate by Culture
97
559
1.91
7.00
2.2
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
93
533
1.91
6.82
2.4
2.3
%
24.4
22.7
0.51
83
458
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
115
707
1.81
6.76
3.4
2.8
mmol/l
2.5
2.4
0.41
106
627
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
14
7.27
6.72
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
33
123
2.80
6.64
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
69
3.44
6.63
1.3
1.3
u/ml
4.3
4.6
0.06
13
31
(3013707) Erythrocyte sedimentation rate by Westergren method
359
3001
1.66
6.30
5.1
4.0
mm/h
13.9
11.1
2.36
337
2771
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
68
360
2.03
6.25
2.6
2.3
g/l
0.2
0.2
0.31
68
339
(3024928) Oxygen saturation in Venous blood
24
77
3.22
6.24
13.0
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
238
1806
1.60
6.21
13.4
8.7
e9/l
0.0
0.0
0.05
182
1470
(1001926) Buprenorphine [Presence] in Urine by Screen method
36
148
2.54
6.01
10.9
2.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
570
1.82
6.00
2.4
2.3
g/l
2.3
2.4
0.05
90
523
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
361
3061
1.61
5.59
4.9
3.9
pmol/l
14.6
14.7
0.22
335
2809
(3049717) Cytology report of Urine Cyto stain
34
141
2.51
5.58
1.8
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
333
2772
1.58
5.57
4.5
3.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
122
806
1.68
5.46
1.8
1.4
g/l
2.6
2.4
0.29
73
507
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
149
2.45
5.45
1.5
1.6
mu/l
445.9
286.4
0.99
30
135
(3021879) Hepatitis B virus core Ab [Presence] in Serum
57
298
2.03
5.42
1.6
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
113
2.66
5.39
1.4
1.4
ug/g
246.9
307.5
0.79
18
69
(3016879) Cocaine [Presence] in Urine
38
169
2.35
5.38
11.2
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
26
4.70
5.28
1.1
2.5
%
12.9
11.4
0.45
12
26
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
6
13.52
5.09
1.8
1.8
umol/l
22.3
13.4
—
8
6
(1761868) Lipid panel - Serum or Plasma
110
1586
0.61
5.00
3.1
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
184
2.21
4.83
11.0
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
184
2.21
4.83
11.2
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
289
1.97
4.82
3.5
3.9
ng/l
76.1
82.0
0.31
48
257
(3019309) Folate [Moles/volume] in Red Blood Cells
109
721
1.65
4.81
1.9
1.7
nmol/l
1031.9
1171.7
1.03
91
553
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
160
2.27
4.68
1.8
2.4
g/l
1.1
1.5
1.88
29
143
(3011288) Drugs identified in Urine by Screen method
29
124
2.42
4.50
10.0
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
452
4134
1.82
4.49
28.4
13.1
mg/l
20.0
22.3
1.04
412
3250
(3027944) Amphetamines [Presence] in Urine
38
183
2.16
4.49
11.9
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
204
2.10
4.46
4.3
4.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
184
2.15
4.43
11.1
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
36
171
2.19
4.40
4.6
4.5
mmol/l
25.2
25.1
0.13
31
163
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
66
2.95
4.38
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
152
2.25
4.34
3.0
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
31
3.94
4.28
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
96
2.57
4.28
1.4
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
67
2.91
4.27
2.4
2.5
%
15.1
15.8
—
7
33
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
73
2.81
4.23
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
414
3716
1.61
4.22
6.1
4.6
mu/l
1.9
2.2
0.42
391
3417
(3023511) Choriogonadotropin [Units/volume] in Urine
22
85
2.66
4.19
1.9
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
80
2.69
4.11
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
87
565
1.65
4.10
3.7
1.9
%
1.6
1.5
1.15
79
505
(3022806) Fractional oxyhemoglobin in Capillary blood
14
42
3.40
4.07
2.1
1.8
%
89.2
89.3
0.02
14
42
(3047181) Lactate [Moles/volume] in Blood
25
106
2.43
3.97
5.4
5.7
mmol/l
1.2
1.3
0.38
18
93
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
12
33
3.70
3.94
17.1
19.7
nmol/l
1238.6
1620.2
0.72
12
33
(3030981) Hyaline casts [#/volume] in Urine by Automated count
41
215
1.99
3.90
4.2
3.0
e6/l
0.2
0.1
0.80
41
206
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
11
7.37
3.87
2.7
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
71
2.74
3.86
3.8
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
53
304
1.83
3.86
3.3
3.0
e9/l
63.6
69.2
0.57
36
240
(3027945) Reticulocytes/100 erythrocytes in Blood
69
430
1.70
3.80
3.1
3.0
%
1.7
1.8
0.30
56
390
(3037522) Nuclear Ab [Titer] in Serum
83
544
1.63
3.77
1.5
1.3
titre
1120.0
487.2
0.70
11
127
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
90
2.51
3.77
1.2
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
326
2817
1.44
3.70
4.9
3.0
u/l
63.6
44.9
1.86
311
2662
(3001122) Ferritin [Mass/volume] in Serum or Plasma
222
1792
1.42
3.70
3.2
2.7
ug/l
110.4
122.1
0.40
206
1666
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
56
2.92
3.66
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
56
2.92
3.66
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
56
2.92
3.66
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
98
2.41
3.63
1.2
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
21
86
2.50
3.59
1.3
1.6
e6/l
24054.9
14612.2
—
10
64
(4268621)
14
46
3.10
3.55
2.2
2.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
57
2.87
3.55
1.3
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
17
5.37
3.52
3.8
2.6
u/ml
666.2
739.5
—
9
17
(46235355) HIV 1 and 2 tests - Meaningful Use set
107
756
1.53
3.51
2.1
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.23
3.51
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
62
387
1.69
3.40
2.6
1.9
nmol/l
358.5
380.2
0.34
57
357
(4062490)
13
42
3.15
3.39
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
54
2.83
3.28
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
134
1005
1.45
3.26
3.2
2.5
umol/l
3082.7
5935.6
0.44
118
887
(3006653) Thiamine [Moles/volume] in Blood
9
19
4.80
3.25
1.1
1.3
nmol/l
152.1
145.5
—
9
19
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
418
3825
1.51
3.23
24.3
12.0
ml/min/173m2
85.8
83.4
1.30
360
3140
(3020891) Body temperature
29
144
2.08
3.22
12.7
4.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
55
2.78
3.18
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
55
2.78
3.18
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
98
2.30
3.17
1.6
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
50
301
1.73
3.13
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
22
99
2.28
3.10
5.7
3.6
mg/l
34.2
122.7
0.79
22
82
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
22
99
2.28
3.10
5.7
3.6
mg/l
33.4
29.4
0.15
22
82
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
56
2.73
3.08
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
22
100
2.25
3.04
5.0
2.8
ph
7.4
7.4
0.65
16
83
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
94
2.29
3.00
2.8
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
27
503
0.51
2.99
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
40
3.05
2.99
3.5
3.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
5
10.08
2.98
12.8
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
16
63
2.59
2.98
18.4
2.0
%
66.0
62.5
0.19
16
63
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
89
629
1.50
2.91
1.8
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
43
254
1.76
2.88
1.8
3.4
pmol/l
4.3
4.6
1.01
35
221
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
110
2.14
2.83
1.5
1.5
u/l
12.9
9.5
0.40
17
93
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
315
2772
1.36
2.80
3.2
3.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
31
3.27
2.78
3.8
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
68
458
1.56
2.77
1.4
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
42
2.90
2.76
1.8
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
117
890
1.41
2.60
1.3
1.3
u/ml
0.7
1.4
1.42
21
237
(3024263) Appearance of Synovial fluid
8
20
4.05
2.57
1.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
75
2.31
2.53
1.2
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
134
1050
1.37
2.49
5.6
3.7
estimate
0.0
0.0
0.80
40
365
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
21
3.85
2.47
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
21
3.85
2.47
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
32
182
1.81
2.46
3.9
4.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
12
5.04
2.41
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
27
3.37
2.40
2.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
146
1166
1.35
2.40
6.0
3.4
mmol/l
7.9
7.7
0.18
134
979
(3044941) Cell count panel - Synovial fluid
14
58
2.45
2.39
1.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
8
6.30
2.37
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.68
2.37
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
192
1599
1.32
2.37
2.3
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
187
1553
1.32
2.35
5.2
3.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
106
807
1.40
2.33
1.5
1.8
pmol/l
96471015.1
7310367.5
0.44
85
684
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
141
1.89
2.32
4.0
2.1
u/l
7697.1
3778.1
—
8
56
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
35
2.89
2.31
1.1
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
35
2.89
2.31
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
35
2.89
2.31
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
35
2.89
2.31
1.1
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
66
2.31
2.26
1.1
1.1
iu/ml
1.4
113.9
—
5
19
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.60
2.22
1.4
1.2
—
—
—
0
0
(44806118)
12
48
2.54
2.20
1.3
1.6
—
—
—
0
0
(44790048)
12
48
2.54
2.20
1.3
1.6
—
—
—
0
0
(44790047)
12
48
2.54
2.20
1.3
1.6
—
—
—
0
0
(44790049)
12
48
2.54
2.20
1.3
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
11
42
2.65
2.20
1.3
14.1
mmol/l
5.8
6.6
—
6
34
(40761535) Cells panel - Urine sediment
48
316
1.57
2.18
3.9
3.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
14
4.32
2.15
1.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
49
2.48
2.12
1.2
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
25
3.23
2.10
1.9
2.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
31
2.94
2.08
1.8
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
402
3741
1.35
2.07
6.1
5.5
mmol/mol
39.9
39.8
0.08
382
3511
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
472
0.59
2.05
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
83
2.08
2.03
4.8
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
97
2.00
2.03
1.3
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
38
2.66
2.02
1.3
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.1
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
70
511
1.43
1.96
3.0
2.6
ug/g
127.1
122.3
0.04
63
415
(3000494) Fungus identified in Specimen by Culture
67
486
1.44
1.94
1.7
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
39
2.60
1.93
3.7
2.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
415
3895
1.35
1.90
5.2
4.3
mmol/l
6.0
5.9
0.34
387
3583
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
286
1.55
1.89
4.0
2.7
ml/min/173m2
60.4
70.6
1.15
16
116
(3002385) Erythrocyte distribution width [Ratio]
373
3453
1.30
1.86
34.0
15.9
%
14.0
13.6
3.66
368
3393
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
399
0.58
1.85
1.7
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
12
4.20
1.82
3.8
14.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
53
2.29
1.82
1.1
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
25
146
1.75
1.81
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
41
2.47
1.76
1.2
1.8
—
—
—
0
0
(4035726)
48
333
1.49
1.76
1.6
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
18
3.36
1.75
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
280
0.52
1.73
1.1
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
24
2.94
1.73
1.9
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
43
293
1.51
1.71
1.2
1.2
iu/ml
235.7
171.3
0.30
16
119
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
18
97
1.89
1.68
3.9
2.3
mg/l
12.7
12.3
0.09
18
89
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
388
1.44
1.66
5.5
3.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
25
2.82
1.65
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
27
166
1.66
1.65
3.0
2.2
u/l
36.3
39.9
0.36
22
151
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
49
2.27
1.64
1.1
1.3
nmol/l
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
14
3.60
1.62
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
77
1.98
1.60
1.8
2.1
g/l
132.9
129.5
—
10
56
(40768795) Lymph node Pathology biopsy report
8
32
2.52
1.60
1.1
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
20
3.02
1.58
4.0
2.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
20
3.02
1.58
1.2
3.2
nmol/l
54.5
66.5
—
6
20
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
50
2.23
1.58
1.4
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
71
2.00
1.55
5.0
3.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
15
3.36
1.52
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
124
1.72
1.49
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
37
2.46
1.48
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
38
2.39
1.46
1.6
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
38
2.39
1.46
1.0
1.2
—
68.0
—
0
5
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
66
2.00
1.44
2.2
3.3
—
996.7
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
141
1.66
1.44
1.5
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
16
3.15
1.44
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
22
2.75
1.44
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
53
2.10
1.39
1.5
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
120
0.41
1.39
1.8
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
192
1.54
1.35
2.1
1.6
—
—
—
0
0
(4024509)
6
24
2.52
1.30
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
132
1122
1.24
1.29
4.3
4.1
mg/mmol
7.2
10.0
0.51
93
727
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
146
1.60
1.28
2.6
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
146
1.60
1.28
5.7
4.3
g/l
0.3
0.3
0.06
12
57
(3012516) Albumin [Mass/volume] in Urine
125
1061
1.24
1.24
3.7
3.3
mg/l
970.0
369.4
0.43
92
698
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
56
1.99
1.23
1.5
1.3
nmol/l
0.4
0.5
0.96
11
51
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
78
1.82
1.22
1.7
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
19
2.65
1.22
2.0
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
19
2.65
1.22
2.0
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
15
249
0.59
1.21
1.3
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
248
1.44
1.20
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
62
484
1.32
1.20
1.1
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(4281824)
8
38
2.12
1.19
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
79
1.79
1.18
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
242
1.43
1.15
2.4
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
160
1.52
1.11
2.9
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
128
1.59
1.10
1.5
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
452
4371
1.30
1.09
16.6
9.7
u/l
27.0
26.9
0.03
441
4231
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
32
2.20
1.08
1.0
1.3
—
—
—
0
0
(4010399)
37
271
1.39
1.08
1.2
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
74
1.78
1.07
1.6
1.2
u/ml
393.9
240.5
—
8
39
(4146454)
7
34
2.07
1.03
3.1
3.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
47
1.93
1.02
1.8
2.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
83
1.71
1.02
2.4
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
35
2.01
1.00
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
35
2.01
1.00
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
35
2.01
1.00
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
36
1.96
0.97
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
36
1.96
0.97
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
36
1.96
0.97
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
117
1.56
0.95
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
101
1.60
0.94
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
539
1.26
0.94
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
27
2.24
0.93
1.7
4.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
52
1.74
0.92
1.9
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
130
1142
1.19
0.91
4.7
3.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
43
1.87
0.87
1.5
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
30
2.01
0.87
1.3
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
72
1.68
0.86
2.3
2.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
20
137
1.48
0.85
1.5
1.9
nmol/l
33.5
36.2
0.25
20
130
(3019225) pH of Specimen
46
364
1.29
0.85
4.4
4.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.83
1.1
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
444
4316
1.22
0.79
21.4
12.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
97
0.51
0.79
1.2
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
235
1.34
0.78
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
209
1.36
0.77
1.4
1.4
iu/l
29.9
26.0
0.26
22
180
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
202
1.36
0.74
2.5
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
55
1.65
0.74
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
55
1.65
0.74
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
55
1.65
0.74
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
68
1.63
0.72
1.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.0
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
26
1.93
0.71
1.2
1.1
—
7.1
—
0
9
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
58
1.56
0.70
1.1
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
135
1.42
0.70
1.3
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
127
1.43
0.69
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
128
1.42
0.66
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
123
1105
1.15
0.65
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
129
1.41
0.64
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
63
1.60
0.62
1.5
1.3
—
—
—
0
0
(44813793)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
35
1.72
0.58
3.2
2.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
54
459
1.20
0.57
8.7
6.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
212
1.29
0.56
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
168
1.32
0.56
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.56
1.5
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
73
639
1.17
0.56
1.3
1.3
u/ml
41.5
14.1
0.30
22
260
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
78
687
1.16
0.55
1.4
1.3
iu/ml
27.4
33.7
0.23
33
226
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
116
1.39
0.55
1.3
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
2.2
2.7
nmol/l
2.7
7.0
—
6
38
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
38
1.59
0.54
1.5
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
39
1.54
0.53
1.0
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
40
1.51
0.51
3.7
4.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
92
1.42
0.51
1.5
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
41
1.47
0.50
3.0
2.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.5
1.8
ug/l
16.0
17.1
—
6
41
(3019832) Treponema pallidum Ab [Presence] in Serum
44
373
1.20
0.49
1.6
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
1.3
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.4
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
47
1.50
0.47
1.3
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
68
1.48
0.47
2.2
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
175
0.74
0.45
1.3
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
33
1.52
0.41
3.2
2.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
32.9
—
0
15
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
31.5
—
0
13
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
71
1.42
0.39
1.2
1.1
—
11.8
—
0
6
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
151
1.27
0.39
2.4
3.3
u/ml
225.4
1273.4
0.58
13
129
(3009542) Hematocrit [Volume Fraction] of Blood
391
3822
1.10
0.38
31.1
13.8
%
39.0
40.4
2.21
290
2884
(40768443) Skin Pathology biopsy report
21
170
1.25
0.37
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
37
1.35
0.37
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
72
1.40
0.37
2.4
3.3
%
39.8
56.8
—
10
72
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
77
0.65
0.36
1.2
1.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
43
1.40
0.35
1.7
1.6
—
—
—
0
0
(3013512) EKG study
117
1094
1.09
0.33
4.4
3.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
100
0.70
0.31
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
121
1.25
0.28
2.0
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
2.0
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
84
785
1.08
0.25
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
398
1.12
0.25
2.5
4.3
ug/l
11.3
39.6
0.74
33
328
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
137
0.80
0.24
1.4
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
395
3893
1.06
0.22
4.4
3.8
mmol/l
1.4
1.3
2.60
374
3609
(3012441) Differential panel - Pleural fluid
5
42
1.19
0.21
1.4
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
28
314
0.89
0.21
5.4
4.4
%
0.0
0.1
—
9
92
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
0.4
—
0
9
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.1
—
0
9
(40765096) Chromosome analysis panel by Banding
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
114
0.79
0.20
1.2
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
23
203
1.14
0.19
1.1
1.1
—
6.2
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
100
954
1.06
0.18
3.9
4.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
63
1.11
0.17
1.3
1.5
—
—
—
0
0
(4034850)
13
152
0.85
0.17
36.6
9.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
70
1.15
0.16
2.3
3.2
e9/l
3.1
4.3
—
8
70
(3003740) Influenza virus B Ag [Presence] in Specimen
6
78
0.77
0.15
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
88
0.79
0.14
1.3
1.2
—
—
—
0
0
(4094501)
8
100
0.80
0.13
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
110
0.81
0.13
3.9
5.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
477
0.94
0.12
4.8
4.3
%
31.5
31.3
0.04
34
330
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
209
0.91
0.11
1.1
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
462
4596
1.06
0.10
38.6
19.2
e9/l
254.3
250.4
0.59
451
4499
(3003434) Protein [Mass/volume] in Pleural fluid
5
44
1.14
0.10
1.6
1.4
g/l
32.2
33.4
—
5
38
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
428
1.06
0.10
1.7
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
45
1.11
0.10
1.6
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
40
421
0.95
0.09
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1022
1.03
0.09
1.9
1.7
mmol/l
1.7
1.4
1.25
92
864
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
54
1.11
0.09
1.2
1.3
—
30.1
—
0
5
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
146
1.10
0.08
1.1
1.3
—
2.6
—
0
11
(3026361) Erythrocytes [#/volume] in Blood
462
4600
1.05
0.08
38.8
19.2
e12/l
4.4
4.5
3.82
448
4492
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
71
0.84
0.07
1.5
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
71
0.84
0.07
2.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
59
610
0.96
0.07
1.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
409
4113
0.97
0.07
5.5
4.6
mmol/l
2.7
2.8
1.38
391
3815
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
85
1.06
0.07
1.0
1.2
—
1.2
—
0
7
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
400
4023
0.97
0.07
5.0
4.2
mmol/l
1.4
1.4
3.08
382
3742
(1002224) Polysomnography panel
20
214
0.93
0.07
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
462
4602
1.04
0.07
38.8
19.2
e9/l
7.0
6.7
1.19
448
4490
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
52
502
1.04
0.07
2.2
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
128
1.10
0.06
1.5
1.6
iu/ml
0.0
0.0
—
5
28
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
132
0.91
0.06
1.3
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
462
4603
1.04
0.06
38.9
19.3
g/l
133.2
136.6
5.09
456
4544
(3017181) Myelocytes/100 leukocytes in Blood
35
336
1.04
0.05
4.6
4.2
%
0.5
0.9
0.34
11
104
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
70
717
0.97
0.05
2.5
2.7
ug/l
0.9
0.8
0.16
53
436
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
99
976
1.02
0.03
3.4
4.0
%
23.5
21.4
0.36
38
420
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
212
1.04
0.02
3.0
2.6
u/ml
80.4
46.3
0.29
22
201
(3025159) Blasts/100 leukocytes in Blood
29
298
0.97
0.02
5.3
4.4
%
0.0
0.1
—
9
82
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
124
1250
0.99
0.02
4.0
4.4
ug/l
2.4
2.4
0.01
112
1124
(40761536) Microorganisms panel - Urine sediment
34
332
1.03
0.02
6.2
3.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
405
4043
1.01
0.01
5.0
4.3
mmol/l
4.5
4.7
1.70
387
3785
(3017732) Neutrophils [#/volume] in Blood
29
284
1.02
0.00
7.1
2.2
e9/l
3.8
3.9
0.11
21
225
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
115
0.96
0.00
1.3
1.3
—
28.8
—
0
6
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
456
1.01
0.00
2.2
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
30
303
0.99
0.00
4.1
4.1
%
0.1
0.4
—
8
73
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
182
0.99
0.00
1.8
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
88
0.91
0.00
1.3
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
64
0.94
0.00
1.8
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
7.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
72
0.97
0.00
1.1
1.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
3.5
—
3221.0
—
0
6
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
56.0
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_PARALOTHUNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PARALOTHUNS | 2.863 [2.26, 3.63] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 320 out of 1060 females with G6_PARALOTHUNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PARALOTHUNS | 2.83 [2.28, 3.52] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 413 out of 1080 males with G6_PARALOTHUNS died.
Mortality risk
Mortality risk for people of age
years, who have G6_PARALOTHUNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.199% | 0.461% |
| 5 | 1.319% | 3.017% |
| 10 | 3.301% | 7.971% |
| 15 | 6.249% | 14.537% |
| 20 | 10.48% | 24.181% |
Relationships between endpoints
↥Index endpoint: G6_PARALOTHUNS – Other and unspecified paralytic syndromes
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data